Quanta Secures Over $60M in Series E Funding

Deal News | Dec 02, 2024 | Goodwin

Quanta Dialysis Technologies has successfully raised over $60 million in a Series E funding round, bolstered by key investors Novo Holdings, Glenview Capital, and b2venture, with existing investors also reaffirming their support. This substantial investment underscores the company's commitment to enhancing the accessibility of dialysis treatment with its innovative Quanta Dialysis System. Notably, the funds are earmarked to extend Quanta's commercial operations within the US, while reinforcing their ongoing dedication to innovation within the life sciences sector. Quanta's advanced dialysis system is distinctive for its ability to be operated across diverse care environments by a wide array of users, ensuring that kidney replacement therapy can be brought directly to patients. The legal advisory for the financing was facilitated by Goodwin's life sciences team, led by professionals including Sophie McGrath and Richard Bloomfield.

Sectors

  • Life Sciences
  • Medical Devices

Geography

  • United Kingdom – Quanta Dialysis Technologies is headquartered in the UK and is expanding its operations from there.
  • United States – Quanta plans to use the raised funds to expand its commercial presence in the US market.

Industry

  • Life Sciences – Quanta Dialysis Technologies operates within the life sciences industry, focusing on innovative healthcare solutions for dialysis treatment.
  • Medical Devices – The company's primary product is the Quanta Dialysis System, a medical device designed for kidney replacement therapy.

Financials

  • over $60 million – The amount raised by Quanta Dialysis Technologies in its Series E funding round.

Participants

NameRoleTypeDescription
Quanta Dialysis TechnologiesTarget CompanyCompanyA medical device company focused on making dialysis accessible with the Quanta Dialysis System.
Novo HoldingsLead InvestorCompanyA major global life sciences investor playing a key role in Quanta's Series E funding round.
Glenview CapitalInvestorCompanyAn investment management firm involved in Quanta's Series E funding.
b2ventureInvestorCompanyInvestment firm participating in Quanta's funding round.
GoodwinLegal AdvisorCompanyProvided legal advisory for Quanta's Series E funding, with representatives including Sophie McGrath and Richard Bloomfield.